Eli Lilly releases single-dose vials of Zepbound at half the price of other obesity meds

Eli Lilly will begin selling single-dose vials of its drug tirzepatide, marketed as Zepbound for weight loss, and price them at least 50% lower than …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies 26.09.2024 / 07:30 CET/CEST

September 27, 2024

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Conference/Study results 27.09.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz

September 28, 2023

Patent Filed by GlycoMimetics Inc for Treating Cancer with Compound Formula (I)

Share this article According to GlobalData’s company profile on GlycoMimetics, Cancer treatment biomarkers was a key innovation area identified from patents. GlycoMimetics‘s grant share as

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.